MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, BDTX made $70M in revenue. $22.444M in net income. Net profit margin of 32.06%.

Income Overview

Revenue
$70M
Net Income
$22.444M
Net Profit Margin
32.06%
EPS
$0.39
Unit: Million (M) dollars

Income Statement
2025-12-31
License revenue
70
Research and development
33.558
General and administrative
16.572
Impairment of right-of-use assets and property and equipment
7.348
Total operating expenses
57.478
Income (loss) from operations
12.522
Interest income
4.061
Other income (expense)
5.784
Total other income (expense), net
9.845
Net income (loss)
22.367
Change in unrealized (loss) gain on investments, net
0.077
Comprehensive income (loss)
22.444
Basic EPS
0.39
Diluted EPS
0.39
Basic Average Shares
56,868,111
Diluted Average Shares
57,562,746
Unit: Million (M) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
License revenue$70M Other income(expense)$5.784M Interest income$4.061M Income (loss) fromoperations$12.522M Total other income(expense), net$9.845M Total operatingexpenses$57.478M Net income (loss)$22.367M Change in unrealized(loss) gain on...$0.077M Research and development$33.558M General andadministrative$16.572M Impairment of right-of-useassets and property and...$7.348M Comprehensive income (loss)$22.444M

Black Diamond Therapeutics, Inc. (BDTX)

Black Diamond Therapeutics, Inc. (BDTX)